These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38765596)

  • 41. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families.
    Scott P; Ouimet D; Proulx Y; Trouvé ML; Guay G; Gagnon B; Valiquette L; Bonnardeaux A
    J Am Soc Nephrol; 1998 Mar; 9(3):425-32. PubMed ID: 9513904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.
    O'Keeffe DT; Tebben PJ; Kumar R; Singh RJ; Wu Y; Wermers RA
    Osteoporos Int; 2016 Oct; 27(10):3121-5. PubMed ID: 27129455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Metabolic effects of Cholecalciferol supplementation in kidney stone formers with vitamin D deficiency].
    Vitale C; Tricerri A; Bermond F; Fabbrini L; Guiotto C; Marangella M
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.
    Letavernier E; Traxer O; Daudon M; Tligui M; Hubert-Brierre J; Guerrot D; Sebag A; Baud L; Haymann JP
    Clin J Am Soc Nephrol; 2011 May; 6(5):1149-54. PubMed ID: 21441130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and characteristics of genetic disease in adult kidney stone formers.
    Anderegg MA; Olinger EG; Bargagli M; Geraghty R; Taylor L; Nater A; Bruggmann R; Sayer JA; Vogt B; Schaller A; Fuster DG
    Nephrol Dial Transplant; 2024 Mar; ():. PubMed ID: 38544324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Vitamin D Treatment on Dynamics of Stones Formation in the Urinary Tract and Bone Density in Children with Idiopathic Hypercalciuria.
    Milart J; Lewicka A; Jobs K; Wawrzyniak A; Majder-Łopatka M; Kalicki B
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Racial Differences in Risk Factors for Kidney Stone Formation.
    Zisman AL; Coe FL; Cohen AJ; Riedinger CB; Worcester EM
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1166-1173. PubMed ID: 32561654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypercalciuria and stones.
    Lemann J; Worcester EM; Gray RW
    Am J Kidney Dis; 1991 Apr; 17(4):386-91. PubMed ID: 2008904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
    Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CT-Based Diagnosis of Low Vertebral Bone Mineral Density Is Associated with Hypercalciuria and Hypocitraturia on Opportunistic Imaging.
    Patel ND; Ward RD; Calle J; Remer EM; Monga M
    J Endourol; 2018 Sep; 32(9):878-883. PubMed ID: 29954225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure.
    Colussi G; Ganon L; Penco S; De Ferrari ME; Ravera F; Querques M; Primignani P; Holtzman EJ; Dinour D
    Nephrol Dial Transplant; 2014 Mar; 29(3):636-43. PubMed ID: 24235083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
    Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of vitamin D supplementation on vitamin D level, urinary calcium excretion and bone density in patients with hypercalciuria and vitamin D deficiency - preliminary report.
    Milart J; Jobs K; Tłustochowicz M; Pogonowska M; Kalicki B
    Dev Period Med; 2018; 22(2):145-152. PubMed ID: 30056401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).
    De Paolis E; Minucci A; De Bonis M; Scaglione GL; Gervasoni J; Primiano A; Ferraro PM; Cappellani D; Marcocci C; Gambaro G; Capoluongo E
    Clin Chim Acta; 2018 Jul; 482():8-13. PubMed ID: 29574006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.